No evidence of cognitive issues when evolocumab added to statin therapy – Medical Xpress
New York Times |
No evidence of cognitive issues when evolocumab added to statin therapy
Medical Xpress There is no evidence that adding a new cholesterol-lowering drug to treatment with a statin causes memory loss or other problems with cognition or thinking, according to findings from the EBBINGHAUS study, the largest, most rigorously designed study to … Anti-PCSK9 Drugs: An Ingenious Solution for a Problem That’s Mostly Already Solved Why Amgen’s Success Was a Big Disappointment In light of Fourier data, what future for Alnylam and TMC’s PCSK9 inclisiran? |
View original article
Author:
Powered by WPeMatico
Health Topic Contributor
Editors and curators bringing you the latest and most impactful health news. Truly objective, we print links to stories and studies that may contradict one another. If you're searching for news on health studies, alternative health modalities, facts on modern allopathic medicine, and more, we're you're team bringing you the stories and facts that matter.